Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 77, Issue 4, Pages 654-672
Publisher
Wiley
Online
2013-12-19
DOI
10.1111/bcp.12312
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Additive Effects of 5-HTTLPR (Serotonin Transporter) and Tryptophan Hydroxylase 2 G-703T Gene Polymorphisms on the Clinical Response to Citalopram among Children and Adolescents with Depression and Anxiety Disorders
- (2013) Benyamin Rotberg et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Norepinephrine Genes Predict Response Time Variability and Methylphenidate-Induced Changes in Neuropsychological Function in Attention Deficit Hyperactivity Disorder
- (2013) Bung-Nyun Kim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Influence of genetic polymorphisms in the glutamatergic and GABAergic systems and their interactions with environmental stressors on antidepressant response
- (2013) Mengjia Pu et al. PHARMACOGENOMICS
- Pharmacogenetics in major depression: A comprehensive meta-analysis
- (2013) Tomihisa Niitsu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Association of SLC6A4 methylation with early adversity, characteristics and outcomes in depression
- (2013) Hee-Ju Kang et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset
- (2012) Philippe A. Melas et al. FASEB JOURNAL
- Dopaminergic and Noradrenergic Gene Polymorphisms and Response to Methylphenidate in Korean Children with Attention-Deficit/Hyperactivity Disorder: Is There an Interaction?
- (2012) Soon-Beom Hong et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis
- (2012) John Cookson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Influence of an Interaction between Lithium Salts and a Functional Polymorphism in SLC1A2 on the History of Illness in Bipolar Disorder
- (2012) Sara Dallaspezia et al. Molecular Diagnosis & Therapy
- Role of Dopamine Receptors in ADHD: A Systematic Meta-analysis
- (2012) Jing Wu et al. MOLECULAR NEUROBIOLOGY
- Failure to Replicate Influence of GRIK4 and GNB3 Polymorphisms on Treatment Outcome in Major Depression
- (2012) Alessandro Serretti et al. NEUROPSYCHOBIOLOGY
- Study of the association of serotonin transporter triallelic 5-HTTLPR and STin2 VNTR polymorphisms with lithium prophylaxis response in bipolar disorder
- (2012) Hema Tharoor et al. PSYCHIATRIC GENETICS
- Evaluation of genetic models for response in a randomized clinical trial of duloxetine in major depressive disorder
- (2012) John P. Houston et al. PSYCHIATRY RESEARCH
- Serotonin transporter genotype and function in relation to antidepressant response in Koreans
- (2012) Woojae Myung et al. PSYCHOPHARMACOLOGY
- Pharmacogenetic Aspects of Antipsychotic Drug-induced Weight Gain - A Critical Review
- (2012) Gavin P. Reynolds Clinical Psychopharmacology and Neuroscience
- Effects of Genotype and Child Abuse on DNA Methylation and Gene Expression at the Serotonin Transporter
- (2012) Meeshanthini Vijayendran et al. Frontiers in Psychiatry
- Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors
- (2011) Amanda J Sales et al. BRITISH JOURNAL OF PHARMACOLOGY
- Variants of ADRA2A are associated with fasting glucose, blood pressure, body mass index and type 2 diabetes risk: meta-analysis of four prospective studies
- (2011) P. J. Talmud et al. DIABETOLOGIA
- Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy
- (2011) Stefano Porcelli et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Association between type-three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia
- (2011) Jeffrey R. Bishop et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Analysis of Gene Variants Previously Associated With Iloperidone Response in Patients With Schizophrenia Who Are Treated With Risperidone
- (2011) Bonnie A. Fijal et al. JOURNAL OF CLINICAL PSYCHIATRY
- DRD2 Taq1A Polymorphism Modulates Prolactin Secretion Induced by Atypical Antipsychotics in Healthy Volunteers
- (2011) Rosario López-Rodríguez et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response
- (2011) Zhi Xu et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to antipsychotic treatment in patients with schizophrenia
- (2011) Concetta Crisafulli et al. NEUROSCIENCE LETTERS
- Functional consequences of twoHTR2Cpolymorphisms associated with antipsychotic-induced weight gain
- (2011) Matthew J Hill et al. PHARMACOGENOMICS
- Sexual dysfunction in male schizophrenia: influence of antipsychotic drugs, prolactin and polymorphisms of the dopamine D2 receptor genes
- (2011) Xiang Rong Zhang et al. PHARMACOGENOMICS
- Association of the ADRA1A gene and the severity of metabolic abnormalities in patients with schizophrenia
- (2011) Chin Cheng et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Genome-wide association study of theta band event-related oscillations identifies serotonin receptor gene HTR7 influencing risk of alcohol dependence
- (2010) Mark Zlojutro et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- D2Receptor Genetic Variation and Clinical Response to Antipsychotic Drug Treatment: A Meta-Analysis
- (2010) Jian-Ping Zhang et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antidepressant Response and the Serotonin Transporter Gene-Linked Polymorphic Region
- (2010) Matthew J. Taylor et al. BIOLOGICAL PSYCHIATRY
- Adrenergic α2A receptor gene is not associated with methylphenidate response in adults with ADHD
- (2010) Verônica Contini et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Genetics of early-onset obsessive–compulsive disorder
- (2010) Susanne Walitza et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia
- (2010) Shigeyuki Chaki EUROPEAN JOURNAL OF PHARMACOLOGY
- Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction
- (2010) Jian-Ping Zhang et al. Expert Opinion on Drug Metabolism & Toxicology
- Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: A review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry
- (2010) Matthäus Willeit et al. NEUROIMAGE
- DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia
- (2010) Todd Lencz et al. Pharmacogenetics and Genomics
- Systematic analysis of dopamine receptor genes (DRD1–DRD5) in antipsychotic-induced weight gain
- (2010) D J Müller et al. PHARMACOGENOMICS JOURNAL
- Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project
- (2010) R Keers et al. PHARMACOGENOMICS JOURNAL
- Pharacogenetic effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia
- (2010) Mingqing Xu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Depression and the role of genes involved in dopamine metabolism and signalling
- (2010) Esther M. Opmeer et al. PROGRESS IN NEUROBIOLOGY
- A Genomewide Association Study of Response to Lithium for Prevention of Recurrence in Bipolar Disorder
- (2009) Roy H. Perlis et al. AMERICAN JOURNAL OF PSYCHIATRY
- Association of the Glutamate Transporter Gene SLC1A1 With Atypical Antipsychotics–Induced Obsessive-compulsive Symptoms
- (2009) Jun Soo Kwon et al. ARCHIVES OF GENERAL PSYCHIATRY
- Association Between Homozygosity of a G Allele of the Alpha-2a-Adrenergic Receptor Gene and Methylphenidate Response in Korean Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
- (2009) Keun-Ah Cheon et al. BIOLOGICAL PSYCHIATRY
- Analysis of association between the 5-HTTLPR and STin2 polymorphisms in the serotonin-transporter gene and clinical response to a selective serotonin reuptake inhibitor (sertraline) in patients with premature ejaculation
- (2009) Mohammad Reza Safarinejad BJU INTERNATIONAL
- Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis
- (2009) Anna C Need et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms
- (2009) Alexandre Y. Dombrovski et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism
- (2009) Olga O. Yevtushenko et al. JOURNAL OF AFFECTIVE DISORDERS
- Multiple Genetic Factors in Olanzapine-Induced Weight Gain in Schizophrenia Patients
- (2009) Hiroshi Ujike et al. JOURNAL OF CLINICAL PSYCHIATRY
- Applicability of a Genetic Signature for Enhanced Iloperidone Efficacy in the Treatment of Schizophrenia
- (2009) Simona Volpi et al. JOURNAL OF CLINICAL PSYCHIATRY
- Polymorphisms in GRIK4, HTR2A and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment
- (2009) Sonja Horstmann et al. NEUROPSYCHOPHARMACOLOGY
- Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents
- (2009) Chadi A. Calarge et al. Pharmacogenetics and Genomics
- Association of the α2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European–Americans
- (2009) Laertes Sickert et al. PHARMACOGENOMICS
- ADRA1A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics
- (2009) Y-R Liu et al. PHARMACOGENOMICS JOURNAL
- Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia
- (2009) B A Fijal et al. PHARMACOGENOMICS JOURNAL
- Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms
- (2009) Gavin P Reynolds et al. PHARMACOLOGY & THERAPEUTICS
- Adolescent development, hypothalamic-pituitary-adrenal function, and programming of adult learning and memory
- (2009) Cheryl M. McCormick et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Interaction between SERTPR and stressful life events on response to antidepressant treatment
- (2008) Laura Mandelli et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The Alpha 2A-Adrenergic Receptor Gene Polymorphism Modifies Antidepressant Responses to Milnacipran
- (2008) Masataka Wakeno et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Adrenergic α2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type
- (2008) T. L. da Silva et al. JOURNAL OF NEURAL TRANSMISSION
- The —1019 C/G polymorphism of the 5-HT1A receptor gene is associated with negative symptom response to risperidone treatment in schizophrenia patients
- (2008) L. Wang et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study
- (2008) C Lavedan et al. MOLECULAR PSYCHIATRY
- Pathway-based association analysis of genome-wide screening data suggest that genes associated with the ??-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia
- (2008) Toshiya Inada et al. Pharmacogenetics and Genomics
- Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia
- (2008) Rainald Mössner et al. Pharmacogenetics and Genomics
- Twenty-one-base-pair insertion polymorphism creates an enhancer element and potentiates SLC6A1 GABA transporter promoter activity
- (2008) Rungnapa Hirunsatit et al. Pharmacogenetics and Genomics
- Pharmacogenomics with antidepressants in the STAR*D study
- (2008) Eugene Lin et al. PHARMACOGENOMICS
- An investigation of theα1A-adrenergic receptor gene and antipsychotic-induced side-effects
- (2007) Pilar A. Saiz et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started